<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02096029</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00019201</org_study_id>
    <secondary_id>2R01DA021619</secondary_id>
    <nct_id>NCT02096029</nct_id>
  </id_info>
  <brief_title>Tobacco Intervention in Primary Care Treatment Opportunities for Providers</brief_title>
  <acronym>TipTop</acronym>
  <official_title>Brief, Novel Smoking Cessation in Primary Care: A Comparative Effectiveness Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University of South Carolina</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the use of &quot;sampling&quot; of smoking cessation
      medications (nicotine patches and lozenges) among smokers seen in primary care settings. Half
      of study participants will be provided with samples of medication, to use however they wish;
      the other half will not be provided with these samples. All smokers will be advised to quit
      through routine contact with their physician. After the primary care contact, all
      participants will be contacted by phone for three brief follow-up interviews, which will
      involve answering questionnaires about their smoking habits.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2014</start_date>
  <completion_date type="Actual">June 15, 2018</completion_date>
  <primary_completion_date type="Actual">June 15, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Participants With 7-Day Self-Reported Point Prevalence Abstinence</measure>
    <time_frame>From study enrollment through end of six-month follow up</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Any Self-defined Attempt to Stop Smoking Cigarettes</measure>
    <time_frame>From study enrollment through end of six-month follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of Any Smoking Cessation Medication</measure>
    <time_frame>From study enrollment through end of six-month follow up</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1278</enrollment>
  <condition>Smoking</condition>
  <condition>Smoking Cessation</condition>
  <arm_group>
    <arm_group_label>Nicotine Replacement Therapy (NRT)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2 week supply of 4 mg nicotine lozenge and 14 mg nicotine patch</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ask, Advise, Refer (physician brief advice)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ask, Advise, Refer (physician brief advice)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Nicotine Replacement Therapy (NRT) Sampling</intervention_name>
    <description>2 week supply of 4 mg nicotine lozenge and 14 mg nicotine patch</description>
    <arm_group_label>Nicotine Replacement Therapy (NRT)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Ask, Advise, Refer (physician brief advice)</intervention_name>
    <arm_group_label>Ask, Advise, Refer (physician brief advice)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt;=18

          -  daily (25+ days within past 30) cigarette smoker of &gt;5 cigs/day

          -  English speaking

          -  recruited through primary care sites aligned with study

        Exclusion Criteria:

        - no FDA contraindications for use of NRT:

          1. not pregnant, breastfeeding, or planning to become pregnant

          2. no recent (past 3 months) cardiovascular trauma: MI, stroke
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthew J Carpenter, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of South Carolina</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>March 21, 2014</study_first_submitted>
  <study_first_submitted_qc>March 21, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 26, 2014</study_first_posted>
  <results_first_submitted>June 13, 2019</results_first_submitted>
  <results_first_submitted_qc>July 12, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">August 7, 2019</results_first_posted>
  <last_update_submitted>July 12, 2019</last_update_submitted>
  <last_update_submitted_qc>July 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 7, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of South Carolina</investigator_affiliation>
    <investigator_full_name>Matthew Carpenter</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>smoking</keyword>
  <keyword>smoking cessation</keyword>
  <keyword>nicotine replacement therapy</keyword>
  <keyword>primary care</keyword>
  <keyword>comparative effectiveness</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>October 6, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/29/NCT02096029/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Of 1,278 Enrolled:
32 Individuals later found to be ineligible
1 person missing contact info
1,245 = Final Intent to Treat Sample</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Standard Care</title>
          <description>Ask, Advise, Refer (physician brief advice)</description>
        </group>
        <group group_id="P2">
          <title>Standard Care + Nicotine Replacement Therapy (NRT)</title>
          <description>2 week supply of 4 mg nicotine lozenge and 14 mg nicotine patch + Ask, Advise, Refer (physician brief advice)
Nicotine Replacement Therapy (NRT) Sampling: 2 week supply of 4 mg nicotine lozenge and 14 mg nicotine patch</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="652"/>
                <participants group_id="P2" count="593"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="652"/>
                <participants group_id="P2" count="593"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Standard Care</title>
          <description>Ask, Advise, Refer (physician brief advice)</description>
        </group>
        <group group_id="B2">
          <title>Standard Care + Nicotine Replacement Therapy (NRT)</title>
          <description>2 week supply of 4 mg nicotine lozenge and 14 mg nicotine patch + Ask, Advise, Refer (physician brief advice)
Nicotine Replacement Therapy (NRT) Sampling: 2 week supply of 4 mg nicotine lozenge and 14 mg nicotine patch</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="652"/>
            <count group_id="B2" value="593"/>
            <count group_id="B3" value="1245"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51.0" spread="13.6"/>
                    <measurement group_id="B2" value="50.4" spread="13.4"/>
                    <measurement group_id="B3" value="50.7" spread="13.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="365"/>
                    <measurement group_id="B2" value="391"/>
                    <measurement group_id="B3" value="756"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="287"/>
                    <measurement group_id="B2" value="202"/>
                    <measurement group_id="B3" value="489"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>White or African American</title>
              <category_list>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="346"/>
                    <measurement group_id="B2" value="433"/>
                    <measurement group_id="B3" value="779"/>
                  </measurement_list>
                </category>
                <category>
                  <title>African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="306"/>
                    <measurement group_id="B2" value="160"/>
                    <measurement group_id="B3" value="466"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Heaviness of Smoking Index</title>
          <description>HSI: Heaviness of Smoking Index (0-6 scale), where 6 indicates the highest (&quot;worst&quot;) Heaviness of Smoking.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2.6" spread="1.6"/>
                    <measurement group_id="B2" value="2.8" spread="1.4"/>
                    <measurement group_id="B3" value="2.7" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Motivation to Quit</title>
          <description>Motivation to quit smoking in next month (0-10), where 0 indicates no desire to quit within the next month and 10 indicates full intent to quit within the next month.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6.2" spread="3.7"/>
                    <measurement group_id="B2" value="6.4" spread="3.6"/>
                    <measurement group_id="B3" value="6.3" spread="3.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Participants With 7-Day Self-Reported Point Prevalence Abstinence</title>
        <time_frame>From study enrollment through end of six-month follow up</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Care + Nicotine Replacement Therapy (NRT)</title>
            <description>2 week supply of 4 mg nicotine lozenge and 14 mg nicotine patch + Ask, Advise, Refer (physician brief advice)
Nicotine Replacement Therapy (NRT) Sampling: 2 week supply of 4 mg nicotine lozenge and 14 mg nicotine patch</description>
          </group>
          <group group_id="O2">
            <title>Standard Care</title>
            <description>Ask, Advise, Refer (physician brief advice)</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With 7-Day Self-Reported Point Prevalence Abstinence</title>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="593"/>
                <count group_id="O2" value="652"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Any Self-defined Attempt to Stop Smoking Cigarettes</title>
        <time_frame>From study enrollment through end of six-month follow up</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Care + Nicotine Replacement Therapy (NRT)</title>
            <description>2 week supply of 4 mg nicotine lozenge and 14 mg nicotine patch + Ask, Advise, Refer (physician brief advice)
Nicotine Replacement Therapy (NRT) Sampling: 2 week supply of 4 mg nicotine lozenge and 14 mg nicotine patch</description>
          </group>
          <group group_id="O2">
            <title>Standard Care</title>
            <description>Ask, Advise, Refer (physician brief advice)</description>
          </group>
        </group_list>
        <measure>
          <title>Any Self-defined Attempt to Stop Smoking Cigarettes</title>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="593"/>
                <count group_id="O2" value="652"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48"/>
                    <measurement group_id="O2" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Use of Any Smoking Cessation Medication</title>
        <time_frame>From study enrollment through end of six-month follow up</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Care + Nicotine Replacement Therapy (NRT)</title>
            <description>2 week supply of 4 mg nicotine lozenge and 14 mg nicotine patch + Ask, Advise, Refer (physician brief advice)
Nicotine Replacement Therapy (NRT) Sampling: 2 week supply of 4 mg nicotine lozenge and 14 mg nicotine patch</description>
          </group>
          <group group_id="O2">
            <title>Standard Care</title>
            <description>Ask, Advise, Refer (physician brief advice)</description>
          </group>
        </group_list>
        <measure>
          <title>Use of Any Smoking Cessation Medication</title>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="593"/>
                <count group_id="O2" value="652"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                    <measurement group_id="O2" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Study consists of 3 follow-up phone calls at 1 month, 3 months, and 6 months post-baseline clinic visit. Adverse events are asked systematically of both groups, at all three follow-up calls.</time_frame>
      <desc>Adverse Events were monitored/assessed without regard to a specific Adverse Event Term.</desc>
      <group_list>
        <group group_id="E1">
          <title>Standard Care</title>
          <description>Ask, Advise, Refer (physician brief advice)</description>
        </group>
        <group group_id="E2">
          <title>Standard Care + Nicotine Replacement Therapy (NRT)</title>
          <description>2 week supply of 4 mg nicotine lozenge and 14 mg nicotine patch + Ask, Advise, Refer (physician brief advice)
Nicotine Replacement Therapy (NRT) Sampling: 2 week supply of 4 mg nicotine lozenge and 14 mg nicotine patch</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="652"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="593"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="652"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="593"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Surgical and medical procedures</sub_title>
                <counts group_id="E1" events="22" subjects_affected="20" subjects_at_risk="652"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="593"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="289" subjects_at_risk="652"/>
                <counts group_id="E2" subjects_affected="276" subjects_at_risk="593"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Other</sub_title>
                <counts group_id="E1" events="625" subjects_affected="289" subjects_at_risk="652"/>
                <counts group_id="E2" events="596" subjects_affected="276" subjects_at_risk="593"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Amy Boatright, Program Coordinator</name_or_title>
      <organization>Medical University of South Carolina</organization>
      <phone>843-876-2440</phone>
      <email>boatrigh@musc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

